According to Nuvectis Pharma's latest financial reports the company has $19.12 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $19.12 M | -4.34% |
2022-12-31 | $19.99 M | 248.19% |
2021-12-31 | $5.74 M | |
2020-12-31 | $N/A |